Exelon (EXC) director receives 5 deferred phantom share equivalents in cash-settled plan

Rhea-AI Filing Summary

Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.

Exelon Corp director Charisse R. Lillie received a grant of 5 deferred phantom share equivalents tied to Exelon common stock. These were awarded at a reference price of $46.62 per equivalent and increase her deferred phantom share balance to 3,896 equivalents.

The phantom share equivalents are held in an Exelon stock fund account within a multi-fund, non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after her service on the board ends. The balance includes 35 additional equivalents that accrued automatically through dividend reinvestment, highlighting this as compensation and deferral activity rather than open-market trading.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lillie Charisse R

Role null

Type	Security	Shares	Price	Value
Grant/Award	Deferred phantom share equivalents	5	$46.62	$233.10

Holdings After Transaction: Deferred phantom share equivalents — 3,896 shares (Direct, null)

Footnotes (1)

1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors. Balance includes 35 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Key Figures

Phantom share grant: 5 deferred phantom share equivalents Reference price: $46.62 per equivalent Post-transaction balance: 3,896 phantom share equivalents +1 more

4 metrics

Phantom share grant 5 deferred phantom share equivalents Grant to director on 2026-06-30

Reference price $46.62 per equivalent Price used for the 5-unit grant

Post-transaction balance 3,896 phantom share equivalents Total deferred phantom equivalents after the award

Dividend reinvestment accrual 35 phantom share equivalents Additional units from automatic dividend reinvestment

Key Terms

Deferred phantom share equivalents, non-qualified deferred compensation plan, automatic dividend reinvestment

3 terms

Deferred phantom share equivalents financial

"Deferred phantom share equivalents held in the reporting person's Exelon stock fund account"

non-qualified deferred compensation plan financial

"part of a multi-fund, non-qualified deferred compensation plan"

An arrangement where an employer agrees to pay part of an employee’s salary or bonus at a later date, often to attract or keep key staff. Think of it as a company IOU or a delayed paycheck held on the company’s books rather than in a protected retirement account; investors care because these promises create future cash obligations that are typically unsecured and depend on the company’s financial health, affecting risk, liabilities, and cash-flow planning.

automatic dividend reinvestment financial

"includes 35 additional phantom share equivalents accrued to the account through automatic dividend reinvestment"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 04:38 PM Accepted by SEC EDGAR 07/01/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lillie Charisse R

(Last) (First) (Middle)

10 S DEARBORN STREET

54TH FLOOR

(Street)

CHICAGO ILLINOIS 60603

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELON CORP [ EXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred phantom share equivalents	(1)	06/30/2026		A		5		(1)	(1)	Common Stock	5	$46.62	3,896(2)	D

Explanation of Responses:

1. Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.

2. Balance includes 35 additional phantom share equivalents accrued to the account through automatic dividend reinvestment.

Remarks:

	David T. Skinner, attorney-in-fact for Charisse R Lillie	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Exelon (EXC) director Charisse R. Lillie report in this Form 4?

Charisse R. Lillie reported receiving 5 deferred phantom share equivalents. These are cash-settled units referenced to Exelon common stock at $46.62 each, increasing her deferred phantom share balance to 3,896 equivalents under a non-qualified deferred compensation plan.

Are the Exelon (EXC) phantom share equivalents an open-market stock purchase or sale?

No, the phantom share equivalents are a compensation-related award, not an open-market trade. They are part of a non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis when the director’s board service ends.

How many deferred phantom share equivalents does the Exelon (EXC) director hold after this transaction?

After the transaction, the director holds 3,896 phantom share equivalents. This total includes the new 5-unit grant and 35 additional equivalents that accrued automatically through dividend reinvestment in the Exelon stock fund account.

What is the settlement feature of Exelon (EXC) deferred phantom share equivalents?

The phantom share equivalents are settled for cash on a 1-for-1 basis. Upon termination of the director’s service on Exelon’s board, each phantom share equivalent will be paid in cash based on the value of one share of Exelon common stock.

How were dividends handled on the Exelon (EXC) phantom share equivalents account?

Dividends are automatically reinvested into additional phantom share equivalents. The reported balance includes 35 extra equivalents that accrued through automatic dividend reinvestment in the Exelon stock fund within the deferred compensation plan.